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The purpose of this study was to develop liposomal formulations of Asparagus racemosus
root extract (AR1-6) as well as evaluate the physicochemical properties and in vitro tyrosi-
nase inhibitory activity. Liposomes composed of AR1-6 to lipid weight ratio of 1:10 and
lecithin (LEC) or Phospholipon 90G (PC90G) as structural phospholipid at 7:3 molar ratio to
CHOL were prepared by various methods, i.e. chloroform-film (CF), reverse-phase evapo-
ration (REV), polyol dilution (PD), and freeze-drying of monophase solution (MFD) methods.
The results revealed that vesicles prepared by CF and MFD were multilamellar whereas
those prepared by REV and PD were oligolamellar in nature with particle sizes ranging from
0.26 to 13.83 mm. The zeta potentials were in the range of1.5 to 39.3 mV. AR1-6 liposomes
with LEC possessed significantly higher entrapment than those with PC90G. The highest
entrapment efficiency and in vitro tyrosinase inhibitory activity of 69.08% and 25%, respec-
tively, were obtained from liposomes having LEC and prepared by PD method. The tyrosi-
nase inhibitory activity were in the rank order of LEC > PC90G, and PD > CF > REV >MFD. It
could be concluded that the mechanism of vesicle forming in each method of preparation
was the key factor influencing physicochemical properties, particularly vesicle type, size,
surface charge, and entrapment, which were well correlated with the biological activity.
ª 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.ufacturing Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayudhya Road,
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a s i a n j o u rn a l o f p h a rm a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 3 4e1 4 2 1351. Introduction monophase solutions methods, their physicochemical proper-The increase in production and accumulation of melanin are
the cause of a large number of skin ailments, e.g. acquired
hyperpigmentation such as melisma, postinflammatory mel-
anoderma, solar lentigo, etc. The hyperpigmentation of the
epidermis and dermis depend on either increased numbers of
melanocytes or the activity of the enzyme [1]. The melano-
cytes are responsible for the biosynthesis of melanin through
enzymatic conversion of L-tyrosine which leads to the sun-
tanning effect. However, overproduction of melanin pigment
is not desirable, especially on people’s face [2,3].
The plant Asparagus racemosus Willd. (Liliaceae) is
commonly called, in India, Satavari; Satawar or Satmuli in
Hindi; Satavari in Sanskrit; Shatamuli in Bengali, etc. In
Thailand it is called Sam-Sib or Sam-Roi-Rak. The plant is a
spinous under-shrub, with tuberous, short rootstock bearing
numerous succulent tuberous roots (30e100 cm long and
1e2 cm thick), which are silvery white or ash colored exter-
nally and white internally [4]. Pharmacological studies with
animals havemanifested thepotency ofA. racemosus extract as
an antioxidant, anticancer, anti-inflammatory, anti-aging, and
as a substrate of inulinase production for ability in modulating
the immune system [5]. Moreover, the tyrosinase inhibitory
activity as skin whitening effect has also been found from the
investigation of this extract by using dopachrome microplate
assay [6,7]. The root extracts of A. racemosus have been
employed in two major forms as methanolic and aqueous ex-
tracts, the products of which were in the form of tablets and
syrup [4]. It has been reported that the major active constitu-
ents of A. racemosus are steroidal saponins (Shatavarins IeIV)
present in the roots [4]. Besides, other active compounds such
as quercetin, rutin, kaempferol, racemofuran, and isoflavone
were also found and identified on the basis of chemical and
spectroscopic evidence. It has previously been observed that a
number of flavonoids were found to manifest the tyrosinase
inhibitory activity with some flavonols acting as copper che-
lators [29]. Besides, quercetin and kaempferol were found to
inhibit the oxidation of L-DOPA catalyzed by mushroom
tyrosinase. As a result, A. racemosus extract might be a candi-
date for therapeutic applications in preventing pigmentation
disorders and other melanin-related health problems as well
as for cosmetic applications for skin whitening effect.
Liposomes have long been receiving a lot of attention during
the past thirty years as drug targeting systems of great poten-
tial. More recently, many new developments have been
emerging in the area of liposomal drugs, from clinically
approved products to new experimental applications, with
gene delivery and cancer therapy still being the principal areas
of interest [8]. The pharmaceutical and pharmacological justi-
fications of the use of liposomes as drug carriers are well
recognized [9]. Numerous liposomal drugs have been approved
for undergoing clinical evaluation, e.g. cytarabine, vincristine,
lurtotecan, platinum compounds, DNA plasmid encoding HLA-
B7anda2microglobulin, all-trans retinoic acid, andE1Agene [8].
In this study, liposomes of A. racemosus extract for thera-
peutic applications in preventing pigmentation disorders were
prepared by various methods, i.e. chloroform-film, reverse-
phase evaporation, polyol dilution, and freeze-drying oftiesand tyrosinase inhibitory activities ofwhichwere evaluated.2. Materials and methods
2.1. Materials
Phosphatidylcholine (PC90G) (Phospholipon 90G) was a gift
from Rhoˆne Poulenc Rorer, Ko¨ln, Germany. Lecithin (LEC) was
purchased from Union Chemicals, Bangkok, Thailand.
Cholesterol (CHOL) and tert-butanol (TBN) were obtained from
Carlo Erba Reagents, Rodano, Italy. Diosgenin (DG) was ob-
tained from SigmaeAldrich, St. Louis, MO, USA. Kojic acid,
3,4-dihydroxy-L-phenylalanine (L-DOPA), mushroom tyrosi-
nase, sucrose (SUC), and vanillin were purchased from
SigmaeAldrich, Steinheim, Germany. Chloroform, meth-
anol, and sulfuric acid, 96% (v/v), were from Labscan, Stillor-
gan, Co Dublin, Ireland. Dibasic potassium phosphate,
monobasic potassiumphosphate, and sodiumhydroxidewere
from Ajax Finechem, Auckland, New Zealand. Absolute
ethanol was from Merck KGaA, Darmstadt, Germany.
2.2. Plant materials
The roots of A. racemosus were collected from Tak Province,
Thailand. The plants were identified by the botanical staff and
the voucher specimen of the plant was deposited in the her-
barium of Faculty of Pharmaceutical Sciences, Naresuan
University, Phitsanulok, Thailand.
2.3. Extraction of A. racemosus roots (AR1-6)
A. racemosus rootsweredried andminced into powder and then
extracted bymacerationwith 95% ethanol at 25 C for 24 h. The
supernatant was filtrated and evaporated by a rotary evapo-
rator (Eyela A-3S, Tokyo Rikakikai, Japan). The dark brown
viscous liquid obtained thereafter was freeze-dried (Christ
LOC-1m, Go¨ttingen, Germany), and kept at 4 C until use.
2.4. Thin layer chromatography (TLC) fingerprint
TLC was performed on silica gel plate, 60F254 (Merck KG,
Darmstadt, Germany) and the developing system of 2:1-
hexane:ethyl acetate was used in this study [10]. Solution of
DG (0.5 mg/ml) in methanol was used as reference [11,12]. The
sample solution of AR1-6 (10 mg/ml) was prepared by dis-
solving in methanol and then filtering through 0.2-mm nylon
membrane filter before use. DG solution and AR1-6 sample at
8 ml were spotted by Autospot equipped with scanner and
camera (CamagLimonat V, Switzerland) on the TLC plate,
which were then air-dried for 5 min and run with the devel-
oping system.After runningwas complete, the platewas dried
in the oven at 100e110 C for 5 min, sprayed with 10 ml ani-
saldehyde-sulfuric acid reagent, and then heated at 105 C for
5e10 min. Afterward, the plate was visualized under visible
(366 nm) and UV light (254 nm) (Perkin Elmer Lambda 35,
Waltham, Massachusetts, USA) and TLC fingerprints were
photographed. This experiment was performed in duplicate.
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Total saponin content of AR1-6 was determined as previously
described [11,13]. Sample solutions of DG (0.5mg/ml) and AR1-
6 (5 mg/ml) in methanol were prepared and filtered through
0.2-mm nylon membrane filter before use. A 250-ml portion of
8% w/v vanillin solution in absolute ethanol was added to
250 ml of sample,whichwas subsequentlymixedwith 2.5ml of
72% v/v sulfuric acid, then incubated in water bath at 60 C for
10 min, and finally cooled in ice bath for 5 min. The absor-
bance of this mixture was measured at 544 nm (Perkin Elmer
Lambda 35, Waltham, Massachusetts, USA). The calibration
curve of DG at a high degree of linearity with correlation co-
efficient (r2) of 0.9998 was achieved across the specified range
of 16.7e83.3 mg/ml. The calibration curve of AR1-6 at a high
degree of linearity with correlation coefficient (r2) of 0.999 was
achieved across the specified range of 1.7e416.7 mg/ml. The
diosgenin equivalent (DGE) (mg/mg extract) was used as
reference in determining the total amount of saponins in AR1-
6. This experiment was performed in triplicate.
2.6. Preparation of AR1-6 liposomes by various methods
2.6.1. Chloroform-film method (CF)
Liposomes containing AR1-6 to lipid weight ratio of 1:10 and
phospholipid (LEC or PC90G) to CHOL molar ratio of 7:3 were
prepared by chloroform film method. Total lipid mixture of
100 mg was dissolved in 20 ml chloroform in a 100-ml round
bottom flask. An accurate amount of 10 mg AR1-6 was dis-
solved in 10 ml methanol, which was subsequently added to
the lipid mixture solution and mixed until homogeneous so-
lution was obtained. The rotary evaporator (Eyela A-3S,
Tokyo Rikakikai, Japan) was used to evaporate out the organic
solvent at 35 C for 1 h. After a dry thin film was obtained on
the bottom of flask, phosphate buffer saline (PBS) pH 7.0 was
added to hydrate the lipid film and mixed continuously at
60 C for 1 min. The dispersion was then completely hydrated
at 54 C for 2 h and subsequently sonicated in an ultrasonic
bath (Branson Model B-12, Branson Cleaning Equipment,
USA) at 25 C for 30 min.
The unentrapped free drug and lipids were separated by
ultracentrifugation (Optima L-80 XP, Fullerton, California,
USA) at 20,000 rpm for 20 min, after which the precipitates
were resuspended and washed several times with PBS pH 7.0
until concentration of drug in the supernatant was less than
2.0 mg/ml. The purified liposomes were finally filled and sealed
in 20-ml vial and kept at 4 C prior to use.
2.6.2. Reverse-phase evaporation method (REV)
Liposomes containing AR1-6 to lipid weight ratio of 1:10 and
phospholipid (LEC or PC90G) to CHOL molar ratio of 7:3 were
prepared by reverse-phase evaporation method as previously
described [14]. Total 100 mg mixture of all compositions was
dissolved in 60 ml chloroform, after which 20 ml of PBS pH 7.0
was added. Subsequently, the dispersion was sonicated using
an ultrasonic bath (Branson Model B-12, Branson Cleaning
Equipment, USA) at 7 C for 10 min to produce water-in-oil
(w/o) emulsion. The emulsion was then transferred to a ro-
tary evaporator (Eyela A-3S, Tokyo Rikakikai, Japan) to slowly
evaporate the solvent out under vacuum at 35 C until the‘viscous gel’ was visualized, indicating the phase reversion
stage into oil-in-water (O/W) emulsion. Continuation of evap-
orationwould finally result in the formation of bilayer structure
of liposomes, which could be characterized by a uniformly
aqueous dispersion. The evaporation process was still pro-
gressing at a slightly higher temperature for a period of time to
remove the organic trace asmuch as possible. Eventually, these
liposomal dispersions were adjusted to initial volume by PBS
pH 7.0. The obtained liposomal dispersions were subsequently
purified as described above, and finally kept at 4 C until use.
2.6.3. Polyol dilution method (PD)
Liposomes containing AR1-6 to lipid weight ratio of 1:10
and phospholipid (LEC or PC90G) to CHOL molar ratio of 7:3
were prepared by polyol dilution method with slight
modification as previously described [15]. Total 100 mg
mixture of all compositions were dissolved together in 4 ml
of propylene glycol at 40 C, which was subsequently
injected into 16 ml of sterile water for injection at 40 C
with continuous stirring at 800 rpm for 15 min, and then
cooled to room temperature. The obtained liposomal dis-
persions were subsequently purified as described above,
and finally kept at 4 C until use.
2.6.4. Freeze-drying of monophase solution method (MFD)
Dry reconstituted liposomal powder containing AR1-6 to lipid
weight ratio of 1:10 and phospholipid (LEC or PC90G) to CHOL
molar ratio of 7:3were preparedby freeze-drying ofmonophase
solutions with slight modification as previously described [16].
PC, CHOL, and AR1-6 were dissolved together in TBN and sub-
sequently mixed with 25%w/v aqueous SUC solution at TBN to
water ratio by weight of 3:2 to obtain a clear isotropic mono-
phase solution, which was then filled into 5-ml freeze-drying
vials. The vials were kept in the freezer at 80 C for 8 h, after
which the frozen samples were freeze-dried (Christ LOC-1m,
Go¨ttingen, Germany) for 24 h at condenser temperature of 50
to 55 C and pressure of 0.18 mbar. The dry reconstituted
liposomal powders obtained were kept at 4 C until use.
2.7. Physicochemical characterizations of prepared AR1-
6 liposomes
2.7.1. Microscopic appearance
In order to examine the microscopic appearance of lamel-
larity of the prepared vesicles, negative staining trans-
mission electron microscopy (TEM) (Jeol JEM-2100, Tokyo,
Japan) was performed. The procedures for staining the
sample were as follows: a drop of liposomal suspension was
placed on a 300-mesh copper grid. After waiting 5 min to
allow the liposome to adsorb to the grid, the excess liquid
was removed with the aid of filter paper. The sample
remained on the grid was stained with 1% phosphotungstic
acid and allowed to air dry for approximately 10 min, then
osmium tetroxide (OsO4) was used as a fixative in order for
vesicle borders to be shown.
2.7.2. Particle size
The volume particle size and size distribution of liposomal
dispersions were measured by laser diffraction using a
Sympatec HELOS system (Mastersizer 2000, Malvern
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0.02e2000 mm. All determinations were carried out in tripli-
cate. The size distribution was characterized by the distri-
bution parameters d10%, d50%, d90% and the distribution
width expressed as ‘span’, which was calculated by the
following equation:
Span ¼ d90% d10%
d50%
(1)
2.7.3. Particle surface charge
The electrophoretic mobility and zeta potential of liposomal
dispersions were determined by laser Doppler electrophoretic
mobility measurements (Zetasizer Nano ZS Series, Malvern
instrument, Worcestershire, UK). The measurement was per-
formed after dispersing the sample in PBS pH 7.0 at room tem-
perature andfilling about 1ml of each liposomal dispersion into
the zeta-potential cell. Briefly, the zeta-potential was detected
by the movement of a charged surface with respect to an adja-
cent liquid phase and the mean value of zeta potential from
three determinations was reported with standard deviation.
2.7.4. Entrapment efficiency
In order to determine the contents of AR1-6 encapsulated in
liposomes, methanol was used to deliberate AR1-6 from li-
posomes. The total saponin content of AR1-6 entrapped in
liposomes was determined as described above. All examina-
tions were carried out in triplicate. The entrapment efficiency
was calculated as follows:% Entrapment efficiency ¼ Amount of drug entrapped in liposomes
Total amount of drug added in liposomes
 100 (2)2.7.5. Tyrosinase inhibitory activity
The assay of enzyme inhibition activity of AR1-6 entrapped in
liposomes was performed by using commercially available
mushroom tyrosinase as previously described [17,18]. L-DOPA
and kojic acid were also used as substrate and positive control
in this experiment, respectively. The activity of tyrosinase
inhibition was determined spectrophotometrically by moni-
toring dopachrome formation at 492 nm. The potential
tyrosinase inhibitor will cause a decrease in dopachrome ab-
sorption. In brief, a 80 ml of 20 mM phosphate buffer (pH 6.8)
was added to eachwell containing 40 ml of sample solution in a
96-well microtiter plate (Nunc, Roskilde, Denmark), then
followed by 40 ml of mushroom tyrosinase solution (427 units/
ml). After each well was mixed and pre-incubated at 25 C for
10 min, a 40 ml of 0.85 mM L-DOPA was added to the mixture,
thenmixed and incubated at 25 C for 20 min. The absorbance
of each well was then measured at 492 nm by using a micro-
plate reader (Infinite 200 PRO, Tecan Trading AG, Ma¨nnedorf,
Switzerland). All sampleswere run in triplicate. The inhibitory
effects of the test samples were expressed as the percentage
of tyrosinase inhibition as follows:
% Tyrosinase inhibition ¼
ðA BÞ  ðC DÞ
ðA BÞ

 100 (3)where A and B denote the optical density at 492 nm of the
mixture without test sample (L-DOPA mixed with enzyme in
buffer; the control) and without test sample and enzyme (L-
DOPA in buffer; the blank), respectively. C and D denote those
with test sample and enzyme (L-DOPA mixed with enzyme
and test sample in buffer; the reaction mixture) and
without enzyme (L-DOPAmixedwith test sample in buffer; the
blank of C ).3. Results and discussion
3.1. Standardization of AR1-6
It has been reported that A. racemosus extracts contained sa-
ponins for the main constituents [19]. Until now, it has been
found that the major constituents of A. racemosus in meth-
anolic extract were steroidal saponins, which were separated,
purified, and named as “Shatavarin”. Ten derivatives of Sha-
tavarinwere numbered as Shatavarin I to X [4,5]. Gautam et al.
[20] reported that A. racemosus aqueous decoction contained
steroidal saponin, alkaloids, proteins, starch, tannin, and
mucilage. Agrawal et al. [21] carried out screening tests and
reported the positive results for steroids, phytosterols, car-
bohydrates, tannins, anthraquinones, saponins, glycosides
and flavonoids, and negative results for terpenoids, amino
acids and alkaloids. Most recently, Visavadiya et al. [19] have
found that most of the phytoconstituents in A. racemosus rootwere saponins (8.833%), while the rest were polyphenols
(1.692%), phytosterols (0.79%), ascorbic acid (0.762%), and fla-
vonoids (0.476%).
Due to the fact that saponins were found in both aqueous
and methanolic extracts of A. racemosus and could be purified
successfully to pure compounds, they were considered as
marker in this study. Standardization of the extract in this
study was to confirm the presence of saponins and to control
the quality of the AR1-6 by examining the TLC fingerprints and
total saponin content.3.2. Thin layer chromatographic (TLC) fingerprints
In this study DG was used as reference for steroid saponins.
The TLC fingerprints of DG and AR1-6 run by using mobile
phase system I (2:1ehexane:ethylacetate) are shown in Fig. 1,
the Rf values and color zones of which are compiled in Table 1.
The anisaldehyde-sulfuric acid reagent was used to detect
phenol, sugar, steroid, and terpene that will turn violet, blue,
red, grey or green. The results showed that DG and AR1-6
exhibited dark yellowish green and light blue color, respec-
tively. These indicated that compounds detected in AR1-6
with this reagent may have the structure of phenol, sugar,
steroid, and/or terpene in their molecules. This information
Fig. 1 e TLC fingerprints under visible light (A), UV long wavelength (366 nm) (B), and UV short wavelength (254 nm) (C) of
AR1-6 sample run by using system I.
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prints of AR1-6would be useful for identification of the extract
and detection of alteration in the extract as well.3.3. Physicochemical characterizations of prepared AR1-
6 liposomes
3.3.1. Microscopic appearance
The transmission electron photomicrographs (TEM) of AR1-6
liposomes having LEC or PC90G as structural lipid are illus-
trated in Figs. 2 and 3, respectively. The existence of the
phospholipid bilayers could be evidenced by the concentric
lamellar structure of vesicles as shown in the TEM, which
appeared to be the oligolamellar type for liposomes prepared
by REV and PD, and multilamellar vesicles for those prepared
by CF and MFD. The differences in lamellar structure and
vesicle type could be attributed to different mechanisms of
vesicle forming by these methods of preparation.Table 1 e Rf values and color zones of TLC fingerprints of
DG and AR1-6 run by using system I under visible light.
Compounds Rf Color under
visible light
DG 0.39 Dark yellowish green
AR1-6 0.10 Grey
0.22 Light blue





0.86 Purple3.3.2. Particle size
It can be seen in Table 2 that the average particle sizes of AR1-
6 liposomes were within the range of approximately
0.2e13.9 mm, depending on their lipid types and methods of
preparation. No attempt was made to reduce the size or
restrict the size distribution of liposomes. The broad distri-
bution width, indicated by ‘Span’, of some formulations such
as thosewith LEC and prepared by CF can be considered as the
strong aggregation of some hydrated vesicles. The smallest
onewas the liposomal formulation having PC90G as structural
lipid and prepared by PD, whereas the largest one was those
with PC90G and prepared by MFD.
AR1-6 liposomes having LEC as structural lipid and pre-
pared by all methods except PD exhibited smaller particle size
than those with PC90G. Such results could be attributed to the
difference in purity and degree of saturation including the
carbon number of the acyl hydrocarbon chains in the phos-
pholipids used, in which PC90G is of a higher purity (94e102%)
than LEC (63%) [22]. Besides, incorporation of phospholipid
with higher degree of saturation into liposomes would yield
larger particles because of the reduction in fluidity or micro-
viscosity of the bilayer. This would enhance the rigidity of the
bilayer membrane above the phase transition temperature,
resulting in an increased elastic modulus and inhibited
curving of the bilayer. Likewise, the unsaturated phospho-
lipids exhibited the conical shape while the saturated ones
exhibited the cylindrical shape. Association of such conical
shape molecules was weaker than that of cylindrical shape
molecules due to a longer intermolecular distance, which
resulted in a higher fluidity of phospholipids containing un-
saturated phospholipids. As expected, vesicles containing
unsaturated phospholipids would result in smaller particle
size than that of saturated ones [22].
Fig. 2 e TEM photomicrographs of prepared AR1-6 liposomes comprising AR1-6 to lipid weight ratio of 1:10 and LEC to CHOL
molar ratio of 7:3 prepared by CF (A), REV (B), PD (C), and MFD (D) methods (magnification 75,0003).
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prepared by PD, in which propylene glycol added would have
affected the hydrophilic-lipophilic balance (HLB) of the sys-
tem, and hence, the change in liposome size accordingly [23].
It has been described that emulsifiers of high HLB values al-
ways formed microsystems with smaller isotropic regions
than ones of lower HLB values [24]. As a result, the mean size
of PD liposomes composed of LEC with higher HLB value
appeared to be larger than those of PC90G.
In order to investigate the effect of method of preparation
on particle size, the obtained liposomes were not subject to
further size reduction. It is clearly demonstrated that
the average particle sizes of vesicles with LEC were found to
be significantly different in rank order as follows:
PD > MFD > CF > REV (P < 0.05, ANOVA), whereas those with
PC90G were significantly different in rank order as follows:
MFD > REV > CF > PD (P < 0.05, ANOVA). Such behaviors may
be attributed to the differences in vesicle type and lamellar
structure of liposomes prepared by these four methods due
to different mechanisms of vesicle forming. Generally,
liposomes prepared by CF and MFD exhibited multilamellar
type whereas those prepared by REV and PD exhibited
oligolamellar in nature. In fact, multilamellar vesiclesmostly possessed quite larger particle size than oligolamellar
ones did.
3.3.3. Particle surface charge
It was found that zeta potentials of AR1-6 liposomes prepared
by these four methods were negative charge in nature within
the range of1.5 to39.3mVas shown inTable 2, whichwould
ensure repulsive force to prevent them from aggregation. Sta-
tistical testing revealed that the zeta potentials of AR1-6 lipo-
somes having LEC were significantly higher negative than
those having PC90G for each method of preparation (P < 0.05,
unpaired t-test). These results suggested that LEC inmediumat
neutral pHmay have a negative charge depending on its degree
of impurity, whilst PC90G will have a zero charge. Therefore,
the slightly negative zeta potential of liposomes was due to the
presence of small amount of other negatively charged phos-
pholipids (phosphatidylserine, phosphatidylinositol) [25].
Speaking in terms of the effect of preparation method, the
rank order of negative zeta potentials of liposomes having
PC90Gwere as follows: REV>CF> PD>MFD,with statistically
significant difference (P< 0.05, ANOVA). It is also interesting to
note that liposomes with PC90G and prepared by MFD were
found to be least negative compared to other methods,
Fig. 3 e TEM photomicrographs of prepared AR1-6 liposomes comprising AR1-6 to lipid weight ratio of 1:10 and PC90G to
CHOL molar ratio of 7:3 prepared by CF (A), REV (B), PD (C), and MFD (D) methods (magnification 75,0003).
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prepared by these methods aforementioned.
3.3.4. Entrapment efficiency
It was found that the minimum value of entrapment effi-
ciency was 42.19% for liposomes having PC90G as structuralTable 2 e Particle size, zeta potential, entrapment efficiency, to
and percentage of tyrosinase inhibition of AR1-6 encapsulated











CF LEC:CHOL 3.24 (53.48) 38.1 (0
PC90G:CHOL 6.32 (1.31) 5.2 (0
REV LEC:CHOL 0.37 (3.92) 36.0 (0
PC90G:CHOL 13.34 (2.25) 6.1 (0
PD LEC:CHOL 8.67 (4.46) 39.3 (0
PC90G:CHOL 0.26 (12.61) 4.0 (0
MFD LEC:CHOL 7.20 (7.88) 37.7 (0
PC90G:CHOL 13.83 (4.94) 1.5 (0
a Average from 3 determinations.lipid and prepared by REV, while the maximum one was as
high as 69.08% for thosewith LEC and prepared by PD (Table 2).
The presence of LEC as structural lipid resulted in a signifi-
cantly higher drug entrapment efficiency than PC90G (P< 0.05,
unpaired t-test). Since the AR1-6 molecule is positively
charged at physiological pH, it could be expected to betal saponin content in terms of diosgenin equivalent (DGE),













.3) 56.59 (0.72) 243.62 (1.51) 17.55 (1.14)
.5) 47.81 (0.69) 225.02 (1.61) 14.52 (0.57)
.9) 48.19 (0.49) 223.61 (1.03) 14.98 (0.94)
.2) 42.19 (0.61) 210.51 (1.52) 12.68 (0.45)
.4) 69.08 (0.64) 273.92 (1.40) 25.00 (0.93)
.1) 63.19 (0.51) 257.97 (1.23) 23.64 (1.20)
.6) 49.40 (1.05) 228.74 (2.44) 13.27 (1.13)
.1) 44.58 (0.14) 216.13 (0.35) 12.06 (0.80)
Fig. 5 e Percentage tyrosinase inhibitioneconcentration
profile of AR1-6. Each data representing mean ± SD of 3
determinations.
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tively charged surface by electrostatic interactions [26].
In addition, there was at least one pair having statistically
significant difference among all values of entrapment effi-
ciency for each lipid type LEC or PC90G (P < 0.05, ANOVA). It
was further shown that almost all pairs of entrapment effi-
ciency with various methods of preparation at the same lipid
type were significantly different statistically (P < 0.05, LSD).
The rank order of entrapment efficiency for vesicles with
LEC was found to be the same as that with PC90G, i.e.
PD> CF>MFD> REV. These results indicated that the heating
process used in PD brought about significantly higher
entrapment efficiency than the solvent technique such as CF
and REV (P< 0.05, ANOVA). Since AR1-6 used in this study was
practically soluble in aqueous medium, the liposomes pre-
pared by PD should be more capable of encapsulating a higher
mass of AR1-6. Besides, the PD did not involve the use of
organic solvents [27].
3.3.5. Total saponin content
Total saponin content in terms of DGE’s of AR1-6 in
liposomes as shown in Table 2 were in the rank order of
PD > CF >MFD > REV, with statistically significant difference
(P < 0.05, ANOVA) for each lipid type. DGE of liposomes with
LEC was significantly higher than those with PC90G for all
pairs of samples with the same method of preparation
(P < 0.05, unpaired t-test). It was apparently shown that AR1-6
liposomes having LEC as structural lipid and prepared by PD
possessed the highest DGE value.
3.3.6. Tyrosinase inhibitory activity
The percentage tyrosinase inhibitioneconcentration profiles of
kojic acid andAR1-6 are depicted in Figs. 4 and 5, respectively. It
is interesting that AR1-6 exhibited substantial inhibitory effect
on the activity of enzyme tyrosinase. The enzyme activity
decreased dramatically with the increasing concentration of
AR1-6. These results revealed that the inhibition of tyrosinase
on the catalysis of the oxidation of L-DOPA displayed a dose-
dependent manner. The IC50 values of kojic acid and AR1-6
were 15.22  0.31 mg/ml and 6.76  0.68 mg/ml, respectively,
indicating that the value of AR1-6 was approximately 410e470Fig. 4 e Percentage tyrosinase inhibitioneconcentration
profile of kojic acid. Each data representing mean ± SD of 3
determinations.folds lower than that of kojic acid, a potent tyrosinase inhibitor
used as reference. The AR1-6 liposomes with LEC as structural
lipid and prepared by PD possessed the highest tyrosinase
inhibitory activity of 25.00% whilst those with PC90G and pre-
pared by MFD exhibited the lowest activity of 12.06% (Table 2).
In general, AR1-6 liposomes with LEC possessed higher inhib-
itory activity than those with PC90G, and the inhibitory activity
could be ranked in the order based on the preparation method
as PD > CF > REV >MFD. Such behavior could be explained by
the same rank order relationship of entrapment efficiency and
DGE of AR1-6 liposomes as mentioned above.
Generally, tyrosinase inhibitors either render the copper
interaction within the active site to be inactive by chelation,
obviating the substrateeenzyme interaction, or inhibit
oxidation via an electrochemical process [28]. The inhibition
exerted by kojic acid is well established to come from its
ability to chelate the copper atoms in the active sites of the
enzyme [29]. It has been reported that the major active
constituents of A. racemosus are steroidal saponins (Shata-
varins IeIV) present in the roots [4]. Besides, other active
compounds such as quercetin, rutin, kaempferol, race-
mofuran, and isoflavone were also found and identified on
the basis of chemical and spectroscopic evidence. It has
previously been observed that a number of flavonoids were
found to manifest the tyrosinase inhibitory activity with
some flavonols acting as copper chelators [29]. Besides,
quercetin and kaempferol were found to inhibit the oxida-
tion of L-DOPA catalyzed by mushroom tyrosinase. Although
the inhibition mechanism of the, herein, crude ethanolic
extract of A. racemosus roots was still unclear, it is possible
that the active groups of this compound is thought to be
hydroxyl group as well as the substituted furan ring (2,3-
dihydro-2,3,3-trimethylfuran moiety) that help increase its
inhibition capacity on mushroom tyrosinase. In addition,
extensive studies of the chemical structures of kojic acid,
kaempferol, and quercetin revealed the structure similarity
especially the 3-hydroxy-4-keto moiety, which is the
important substructure to react with the copper ions of
tyrosinase.
a s i a n j o u rn a l o f p h a rma c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 1 3 4e1 4 21424. Conclusion
AR1-6 liposomeswith LEC or PC90G as structural lipid could be
prepared by CF, REV, PD, and MFD methods. The obtained li-
posomes possessed the size range of 0.26e13.83 mm and
slightly negative charge of 1.5 to 39.3 mV, whereas the
entrapment efficiency and in vitro tyrosinase inhibitory ac-
tivity were 42.19%e69.08% and 12.06%e25.00%, respectively.
Types of lipid and preparation methods significantly influ-
enced the physicochemical properties of liposomes such as
vesicle type, size, surface charge, drug entrapment, and bio-
logical activity.
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